The DOI matches its Crossref record.
Autonomic Neural Dysfunction in Recently Diagnosed Diabetic Subjects
Abstract
Because onset of autonomic neural dysfunction in the diabetic syndrome has not been well established, sensitive and quantitative measures of autonomic nervous system (ANS) function were made in 19 non-insulin-dependent (NIDD) and 14 insulin-dependent (IDD) recent-onset diabetic subjects. The known duration of diabetes mellitus in the NIDD subjects was ≤ 12 mo. The duration in the IDD subjects was ≤ 24 mo. RR-variation during beta adrenergic blockade (an index of an ANS reflex involving the cardiac parasympathetic nervous system [PNS] pathway) was smaller than that of control subjects in both NIDD (P < 0.001) and IDD subjects (P < 0.01). This PNS abnormality was not likely to be due to volume depletion since acute volume depletion induced by furosemide in six normal subjects (1608 ± 105 ml, mean ± SEM) did not change RR-variation. Dark-adapted pupil size after topical PNS blockade (an index of iris sympathetic nervous system [SNS] activity) was also smaller in both groups of diabetic subjects (NIDD, P < 0.01; IDD, P < 0.05). Pupillary latency time (an index of an ANS reflex involving iris PNS pathway) was prolonged in the NIDD subjects (P < 0.005) but was not significantly altered in the IDD subjects. Thus, it would appear that the ANS is impaired soon after the diagnosis of diabetes mellitus. We hypothesize that early impairment of the ANS is common in IDD and NIDD subjects. This finding is consistent with the hypothesis that abnormal carbohydrate metabolism is an important factor in the etiology of diabetic autonomic neuropathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“diabetic autonomic neuropathy is associated with significant increases in morbidity and mortality, including an increased risk of sudden death (37, 42, 43).”
From Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans (2008) · cites this paper as [37]
Citations
Cited by
Sorted by citations
Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1553 · Cited by 2,044
“● Neither age nor type of diabetes are limiting factors in its emergence, being found in young individuals with newly diagnosed type 1 diabetes and older individuals newly diagnosed with type 2 diabetes (5,24,40,44,113,114).”
BackgroundDiabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 812
Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540
Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitus
Fraser, R., Horowitz, M., Maddox, A., Harding, P., Chatterton, B., & Dent, J. (1990) · Diabetologia · doi:10.1007/bf00400569 · Cited by 359
“Hyperglycaemia may suppress vagal nerve activity [30] and be an important factor in the aetiology of autonomic nerve dysfunction [31].”
BackgroundCardiac Autonomic Neuropathy in Diabetes
Pop‐Busui, R. (2010) · Diabetes Care · doi:10.2337/dc09-1294 · Cited by 486
Gastric and oesophageal emptying in patients with Type 2 (non-insulin-dependent) diabetes mellitus
Horowitz, M., Harding, P. E., Maddox, A. F., Wishart, J. M., Akkermans, L. M. A., Chatterton, B. E., & Shearman, D. J. C. (1989) · Diabetologia · doi:10.1007/bf00265086 · Cited by 393
Cardiac autonomic neuropathy in patients with diabetes mellitus
Dimitropoulos, G. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i1.17 · Cited by 364
Pop-Busui, R., Low, P. A., Waberski, B. H., Martin, C. L., Albers, J. W., Feldman, E. L., Sommer, C., Cleary, P. A., Lachin, J. M., & Herman, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.837369 · Cited by 310
Diabetes, Glucose, Insulin, and Heart Rate Variability
Schroeder, E. B., Chambless, L. E., Liao, D., Prineas, R. J., Evans, G. W., Rosamond, W. D., & Heiss, G. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.668 · Cited by 302
Posttraumatic Stress Disorder, Cardiovascular, and Metabolic Disease: A Review of the Evidence
Dedert, E. A., Calhoun, P. S., Watkins, L. L., Sherwood, A., & Beckham, J. C. (2010) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9165-9 · Cited by 263
Autonomic neuropathy: its diagnosis and prognosis
Ewing, D. J., & Clarke, B. F. (1986) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(86)80078-0 · Cited by 258
Valensi, P. E., Pariès, J., & Attali, J. R. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00095-7 · Cited by 247
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy☆
Spallone, V., Bellavere, F., Scionti, L., Maule, S. V., Quadri, R., Bax, G., Melga, P., Viviani, G. L., Esposito, K., & Morganti, R. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.07.005 · Cited by 243
Carnethon, M. R., Prineas, R. J., Temprosa, M., Zhang, Z.-M., Uwaifo, G., Molitch, M. E., & for the Diabetes Prevention Program Research Group (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1729 · Cited by 220
“A utonomic impairment has been identified at the time of diabetes diagnosis, which suggests that impairment may be present after a relatively brief exposure to hyperglycemia or develop in conjunction with obesity or insulin resistance (1,2).”
BackgroundBalcıoğlu, A. S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.80 · Cited by 226
QT Interval Prolongation and Sudden Cardiac Death in Diabetic Autonomic Neuropathy*
Kahn, J. K., Sisson, J. C., & Vinik, A. I. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-751 · Cited by 209
Recognizing and treating diabetic autonomic neuropathy.
Vinik, A., & Erbas, T. A. (2001) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.68.11.928 · Cited by 199
Borden, P., Houtz, J., Leach, S. D., & Kuruvilla, R. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.019 · Cited by 192
“However, given that peripheral nervous system impairments are present at the time of the initial diagnosis of diabetes in some patients (Pfeifer et al. 1984; Lehtinen et al. 1989), it seems likely that neuronal dysfunction may contribute to the progression of diabetes and not merely be a bystander…”
BackgroundAutonomic Neuropathy in Diabetes Mellitus
Verrotti, A., Prezioso, G., Scattoni, R., & Chiarelli, F. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00205 · Cited by 187
“In fact, subclinical DAN can occur within a year of diagnosis in T2DM and within 2 years in T1DM, while first symptoms may onset after years (6, 9, 10).”
BackgroundCardiovascular autonomic neuropathies as complications of diabetes mellitus
Kuehl, M. W., & Stevens, M. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.21 · Cited by 182
Influence of Autonomic Nervous System Dysfunction on the Development of Type 2 Diabetes
Carnethon, M. R., Jacobs, D. R., Sidney, S., & Liu, K. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3035 · Cited by 173
“While autonomic dysfunction is an established complication of diabetes (1), impaired autonomic function is often detected at the time of diabetes diagnosis (2,3).”
BackgroundAssociation between reflux oesophagitis and features of the metabolic syndrome in Japan
Moki, F., Kusano, M., Mizuide, M., Shimoyama, Y., Kawamura, O., TAKAGI, H., IMAI, T., & Mori, M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03454.x · Cited by 150
Gastric and oesophageal emptying in insulin‐dependent diabetes mellitus
Horowitz, M., Harding, P. E., Maddox, A. F., Maddern, G. J., Collins, P., Chatterton, B. E., Wishart, J. M., & Shearman, D. J. C. (1986) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1986.tb00104.x · Cited by 144
Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
Fisher, V. L., & Tahrani, A. A. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s129797 · Cited by 145
“2% in patients newly diagnosed with T2DM,(25) with higher prevalence reported in patients with T2DM and longer diabetes duration.(14,26,27) The prevalence of CAN is often reported to be higher in T2DM compared to T1DM, despite the longer diabetes duration in patients with T1DM; this is likely a reflection of patients…”
BackgroundProceedings of a consensus development conference on standardized measures in diabetic neuropathy
Kahn, R. (1992) · Muscle & Nerve · doi:10.1002/mus.880151014 · Cited by 132
Highly variable gastric emptying in patients with insulin dependent diabetes mellitus.
Nowak, T. V., Johnson, C. P., Kalbfleisch, J. H., Roza, A. M., Wood, C. M., Weisbruch, J. P., & Soergel, K. H. (1995) · Gut · doi:10.1136/gut.37.1.23 · Cited by 127
Vinik, A. I., & Erbas, T. A. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00022-5 · Cited by 133
Pathogenesis of Cardiovascular Disease in Diabetes
Haas, A. V., & McDonnell, M. E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.010 · Cited by 128
Prevalence of Neuropathy in Newly Diagnosed NIDDM and Nondiabetic Control Subjects
Lehtinen, J. M., Uusitupa, M. I. J., Siitonen, O., & Pyörälä, K. (1989) · Diabetes · doi:10.2337/diab.38.10.1307 · Cited by 129
“Autonomic neuropathy in newly diagnosed NIDDM subjects has also been found earlier (16,35), but no prevalence figures are available for comparison.”
BackgroundPrinsloo, G. E., Rauch, L., & Derman, W. E. (2014) · The Physician and Sportsmedicine · doi:10.3810/psm.2014.05.2061 · Cited by 146
Dysfunction of Autonomic Nervous System in Childhood Obesity: A Cross-Sectional Study
Baum, P., Petroff, D., Claßen, J., Kieß, W., & Blüher, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054546 · Cited by 118
“PDD and amplitude, latency of pupillary response and velocity of pupillary constriction and of re-dilation following light stimulation are impaired in diabetic patients and may represent the earliest manifestations of peripheral autonomic neuropathy [9–11].”
BackgroundLieb, D. C., Parson, H. K., Mamikunian, G., & Vinik, A. I. (2011) · Experimental Diabetes Research · doi:10.1155/2012/878760 · Cited by 114
“reported abnormal autonomic responses in a group of 33 newly diagnosed diabetic subjects (duration of diabetes less than 12 months), and suggested that abnormal carbohydrate metabolism was a cause of their ANS abnormalities [22].”
BackgroundHicks, K. K., Seifen, E. E., Stimers, J. R., et al. (1998) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(98)00004-6 · Cited by 112
RR‐variation: The autonomic test of choice in diabetes
Genovely, H., & Pfeifer, M. A. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040305 · Cited by 109
Self-citationCardiac autonomic diabetic neuropathy
Schönauer, M., Thomas, A., Morbach, S., Niebauer, J., Schönauer, U., & Thiele, H. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.047 · Cited by 108
“The clinical presentation is most often a heterogeneous pattern of symptoms in different organ systems, which can lead to misdiagnosis.(2,3) Since they coincide in approximately 50% of cases, in a patient with ADN evidence of sensorimotor diabetic neuropathy should be sought.”
BackgroundRole of sympathovagal interaction in diurnal variation of QT interval
Murakawa, Y., Inoue, H., Nozaki, A., & Sugimoto, T. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90230-v · Cited by 107
Sun, Y., Lai, M., & Lu, C.-J. (2005) · PubMed · Cited by 104
Autonomic influence on cardiovascular performance in diabetic subjects
Roy, T. M., Peterson, H. R., Snider, H. L., Cyrus, J., Broadstone, V. L., Fell, R. D., Rothchild, A. H., Samols, E., & Pfeifer, M. A. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80818-6 · Cited by 106
Self-citationNeuropathy profile of diabetic patients in a pancreas transplantation program
Kennedy, W. R., Navarro, X., & Sutherland, D. E. R. (1995) · Neurology · doi:10.1212/wnl.45.4.773 · Cited by 103
Management of diabetic neuropathy
Cernea, S., & Raz, I. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154867 · Cited by 110
Bharucha, A. E., Charkoudian, N., Andrews, C. N., Camilleri, M., Sletten, D., Zinsmeister, A. R., & Low, P. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2008 · Cited by 98
“(37, 42, 43) The effects of GLP-1 on MSNA need to be confirmed by larger studies in healthy subjects.”
BackgroundWhat Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
Pop‐Busui, R. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9367-6 · Cited by 102
“a year of diagnosis in T2DM and 2 years of diagnosis in T1DM [98].”
BackgroundReduced Heart Rate Variability Among Youth With Type 1 Diabetes
Jaiswal, M., Urbina, E. M., Wadwa, R. P., Talton, J. W., D’Agostino, R. B., Hamman, R. F., Fingerlin, T. E., Daniels, S. R., Marcovina, S. M., Dolan, L. M., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0463 · Cited by 101
“Subclinical CAN has been detected within a year of diagnosis in individuals with type 2 diabetes and within 2 years in individuals with type 1 diabetes (3).”
BackgroundDiabetic Neuropathies: Features and Mechanisms
Zochodne, D. W. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00233.x · Cited by 94
Ziegler, D., Mayer, P. S., & Gries, F. A. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.11.1420 · Cited by 95
Factors associated with hypotension and bradycardia after carotid angioplasty and stenting
Lin, P. H., Zhou, W., Kougias, P., et al. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.07.020 · Cited by 94
Niakan, E., Harati, Y., & Comstock, J. P. (1986) · Metabolism · doi:10.1016/0026-0495(86)90205-2 · Cited by 93
Jaiswal, M., Urbina, E. M., Wadwa, R. P., Talton, J. W., D’Agostino, R. B., Hamman, R. F., Fingerlin, T. E., Daniels, S. R., Marcovina, S. M., Dolan, L. M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0923 · Cited by 89
“There is ample biologic plausibility for the role of hyperglycemia as a common mediator of both abnormalities (31,32).”
BackgroundLong-term effects of finger amputation on stump skin sensibility and digital nerve conduction
Chu, N. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199608)19:8 · Cited by 7
Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Witzel, I., Jelinek, H. F., Khalaf, K. A., Lee, S., Khandoker, A. H., & AlSafar, H. S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00088 · Cited by 89
A Simple Diagnostic Test for Pupillary Abnormality in Diabetic Autonomic Neuropathy
Smith, S. A., & Dewhirst, R. R. (1986) · Diabetic Medicine · doi:10.1111/j.1464-5491.1986.tb00703.x · Cited by 86
Diabetic neuropathy in children and adolescents
Trotta, D., Verrotti, A., Salladini, C., & Chiarelli, F. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00041.x · Cited by 79
Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus
Vanninen, E. J., Mustonen, J. N., Vainio, P. A., Länsimies, E., & Uusitupa, M. I. J. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90622-6 · Cited by 81
Valensi, P. E., Giroux, C., Seeboth-Ghalayini, B., et al. (1997) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(95)00086-0 · Cited by 75
Pupil Abnormalities in Selected Autonomic Neuropathies
Bremner, F., & Smith, S. (2006) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000235564.50518.1b · Cited by 65
“Some observers have used measurement of the pupil response to a large dose of an anticholinergic to assess dilator muscle function and thus, indirectly, the percent of diabetic neuropathy (75,87).”
BackgroundSardu, C., Massetti, M., Rambaldi, P., Gatta, G., Cappabianca, S., Sasso, F. C., Santamaria, M., Volpicelli, M., Ducceschi, V., Signoriello, G., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155243 · Cited by 65
A Comprehensive Review of Neuronal Changes in Diabetics
Luna, R., Manjunatha, R. T., Bollu, B., Jhaveri, S., Avanthika, C., Reddy, N., Saha, T., & Gandhi, F. R. (2021) · Cureus · doi:10.7759/cureus.19142 · Cited by 71
“Subclinical autonomic dysfunction can arise within one year of diagnosis in T2DM patients and within two years in T1DM patients [150].”
BackgroundFactors involved in cardiac autonomic neuropathy in diabetic patients
Valensi, P. E., Huard, J.-P., Giroux, C., & Attali, J. (1997) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00005-6 · Cited by 62
Bruce, D. G., Chisholm, D. J., Storlien, L. H., Kraegen, E. W., & Smythe, G. A. (1992) · Diabetologia · doi:10.1007/bf00399929 · Cited by 64
Schaan, B. D., Lago, P. D., Maeda, C. Y., et al. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004001200016 · Cited by 62
“these complications in autonomic and peripheral nerves (4,5).”
BackgroundWerth, B., Meyer-Wyss, B., Spinas, G., Drewe, J., & Beglinger, C. (1992) · Gut · doi:10.1136/gut.33.9.1199 · Cited by 64
Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction
Musicki, B., Bella, A. J., Bivalacqua, T. J., Davies, K. P., DiSanto, M. E., González-Cadavid, N. F., Hannan, J. L., Kim, N. N., Podlasek, C. A., Wingard, C. J., et al. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.13069 · Cited by 61
Power Spectral Analysis of Heart Rate Variability in Children and Adolescents With IDDM
Wawryk, A. M., Bates, D., & Couper, J. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1416 · Cited by 61
“These changes occurred from the 1st year after diagnosis, which is consistent with previous findings of early abnormalities of autonomic and peripheral nerve function in young adults (14-17).”
ResultNew insights in diabetic autonomic neuropathy in children and adolescents
Verrotti, A., Loiacono, G., Mohn, A., & Chiarelli, F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0710 · Cited by 57
“Subclinical autonomic dysfunction can, however, occur within a year of diagnosis in type 2 diabetes patients and within 2 years in patients with type 1 diabetes ( 5 ).”
BackgroundIs there a glycemic threshold for impaired autonomic control?
Watkins, L. L., Surwit, R. S., Grossman, P., & Sherwood, A. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.826 · Cited by 56
Peripheral Diabetic Neuropathy
Bays, H. E., & Pfeifer, M. A. (1988) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30716-7 · Cited by 54
Self-citationPerano, S. J., Rayner, C. K., Kritas, S., Horowitz, M., Donaghue, K. C., Mpundu‐Kaambwa, C., Giles, L. C., & Couper, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1055 · Cited by 54
Kamenov, Z. A., & Traykov, L. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_15 · Cited by 57
Small bowel bacterial overgrowth and type 1 diabetes.
Ojetti, V., Pitocco, D., Scarpellini, E., et al. (2010) · PubMed · Cited by 53
Debono, M., & Boland, E. G. (2007) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.11.003 · Cited by 51
Autonomic neuropathy and urologic complications in diabetes
Mmonu, N. A., Pop‐Busui, R., Wessells, H., & Sarma, A. V. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102736 · Cited by 56
Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation
Navarro, X., Kennedy, W. R., & Sutherland, D. E. R. (1991) · Diabetologia · doi:10.1007/bf00587633 · Cited by 50
Nakayama, M., Nakamura, J., Hamada, Y., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1093 · Cited by 47
“Powszechnie wiadomo, że neuropatia autonomiczna może rozwinąć się nawet u chorych z krótkotrwałą cukrzycą i przy braku cech neuropatii somatycznej [3, 4].”
Vanninen, E. J., Uusitupa, M. I. J., Länsimies, E., Siitonen, O., & Laitinen, J. H. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb01999.x · Cited by 45
Ullery, B. W., Nathan, D. P., Shang, E. K., et al. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.10.141 · Cited by 44
Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetes
Kazé, A. D., Yuyun, M. F., Erqou, S. A., Fonarow, G. C., & Echouffo-Tcheugui, J. B. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2432 · Cited by 43
Cardiac Autonomic Function Correlates with Arterial Stiffness in the Early Stage of Type 1 Diabetes
Liatis, S., Αλεξιάδου, Κ., Tsiakou, A. G., Makrilakis, K., Katsilambros, Ν., & Tentolouris, N. (2011) · Experimental Diabetes Research · doi:10.1155/2011/957901 · Cited by 39
“It has been reported that subclinical autonomic dysfunction may occur within two years of the diagnosis in patients with T1D [16].”
BackgroundAlternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy
Vinik, A. I., CASELLINI, C. M., & Névoret, M. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.010 · Cited by 38
“A patient diagnosed with diabetes should be suspected of having at least subclinical disturbances of the ANS, which can occur within a year of diagnosis in type 2 diabetic patients and within 2 years in type 1 diabetic patients (Pfeifer et al., 1984).”
BackgroundType 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry
Lerner, A. G., Bernabé‐Ortiz, A., Ticse, R., Hernandez, A. G., Huaylinos, Y., Pinto, M. E., Málaga, G., Checkley, W., Gilman, R. H., Miranda, J. J., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12752 · Cited by 38
Review: Small-Fiber Neuropathy
Alshekhlee, A., Chelimsky, T. C., & Preston, D. C. (2002) · The Neurologist · doi:10.1097/00127893-200207000-00004 · Cited by 36
“8 years), 90% of patients had abnormalities on sweat tests (73).”
BackgroundThe Prevalence of Autonomic and Peripheral Neuropathy in Insulin‐treated Diabetic Sbjects
Flynn, M. D., O'Brien, I. A. D., & Corrall, R. J. M. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00483.x · Cited by 34
Reliability and Validity of Cardiovascular and Vasomotor Autonomic Function Tests
Hartwig, M. S., Cardoso, S., Hathaway, D., et al. (1994) · Diabetes Care · doi:10.2337/diacare.17.12.1433 · Cited by 34
Assessment of Laboratory Methods for Detection of Unsuspected Diabetes in Primary Health Care
Bitzén, P.-O., & Scherstén, B. (1986) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813438609014809 · Cited by 33
Diabetic neuropathy in children and youth: New and emerging risk factors
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13153 · Cited by 30
Screening for Type 2 diabetes mellitus in the UK Indo‐Asian population
Davies, M. J., Ammari, F., Sherriff, C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00012.x · Cited by 31
Autonomic nervous dysfunction in severe pre-eclampsia
Airaksinen, J. K. E., Kirkinen, P. P., & Takkunen, J. T. (1985) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(85)90040-1 · Cited by 31
Diabetes mellitus and cerebrovascular disease: which are the actual data?
Hatzitolios, A. I., Didangelos, T., Zantidis, A., Τζιόμαλος, Κ., Giannakoulas, G. A., & Karamitsos, D. T. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.01.004 · Cited by 31
Progression Rates of Diabetic Neuropathy in Placebo Patients in an 18-Month Clinical Trial
Laudadio, C., & Sima, A. A. F. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00074-3 · Cited by 30
Murakawa, Y., Ajiki, K., Usui, M., Yamashita, T., Oikawa, N., & Inoue, H. (1993) · American Heart Journal · doi:10.1016/s0002-8703(07)80016-0 · Cited by 30
Autonomic dysfunction in women with polycystic ovary syndrome.
Hashim, Z. H., Hamdan, F. B., & Al-Salihi, A. R. (2015) · Europe PMC (PubMed Central) · Cited by 29
Kulur, A. B., Haleagrahara, N., Adhikary, P., & Jeganathan, P. S. (2009) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2009000600008 · Cited by 31
Cho, Y. H., Craig, M. E., Davis, E. A., Cotterill, A. M., Couper, J., Cameron, F. J., Benitez‐Aguirre, P., Dalton, R. N., Dunger, D. B., Jones, T. W., et al. (2015) · Diabetes Care · doi:10.2337/dc14-1848 · Cited by 28
Levy, D. M., Rowley, D. A., & Abraham, R. R. (1992) · Clinical Autonomic Research · doi:10.1007/bf01824304 · Cited by 28
“Number 67 85 Male: Female 3 2 : 3 5 53 : 32 Age, years 42 (12) [19-67] 44 (15) [18-66] Type 1 : Type 2 43:42 Duration diabetes, years 12 (10) [1-34] HbA1 (ref.”
Kalopita, S., Liatis, S., Thomakos, P., Vlahodimitris, I., Stathi, C., Katsilambros, N. L., Tentolouris, N., & Makrilakis, K. (2014) · Journal of Diabetes Research · doi:10.1155/2014/835392 · Cited by 27
“Clinical symptoms of autonomic dysfunction may not appear until long after diabetes onset, but subclinical CAN, manifested by reduced HRV (the earliest indicator ofCAN),may be detected as early aswithin 1-2 years after diagnosis of diabetes [3].”
BackgroundParry, M. J. E., Danielson, K., Brennenstuhl, S., Drennan, I. R., & Morrison, L. J. (2017) · Resuscitation · doi:10.1016/j.resuscitation.2017.01.011 · Cited by 26
Naranjo, C. C., Sanchez-Rodriguez, L. M., Martínez, M. B., Estévez‐Báez, M., & Machado, A. (2017) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2017.05.003 · Cited by 27
Brassard, P., Ferland, A., Bogaty, P. M., Desmeules, M., Jobin, J., & Poirier, P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.025 · Cited by 27
“Subclinical autonomic dysfunction has been shown to be present early after the diagnosis of type 2 diabetes mellitus [37,38].”
BackgroundCho, Y. H., Craig, M. E., Srinivasan, S., Benitez‐Aguirre, P., Mitchell, P. L. R., Jopling, T., & Donaghue, K. C. (2013) · Clinical Endocrinology · doi:10.1111/cen.12238 · Cited by 26
Life after pancreas transplantation
Dunn, T. B. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000045 · Cited by 26
“In this scenario, an individual may be exposed to oscillating hyperglycemia over a longer period of time prior to formal diagnosis, which may explain why subclinical autonomic dysfunction has been observed earlier in type 2 diabetes [31].”
BackgroundKomici, K., Femminella, G. D., de Lucia, C., Cannavò, A., Bencivenga, L., Corbi, G., Leosco, D., Ferrara, N., & Rengo, G. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-0973-2 · Cited by 27
Metadata
- Authors
- Pfeifer, M. A., Weinberg, C. R., Cook, D. L., Reenan, A., Halter, J. B., Ensinck, J. W., & Porte, D.
- Affiliations
- United States Department of Veterans Affairs (US)
- Departments of Medicine and Biostatistics, Universities of Washington and Louisville, The Geriatric Research Education and Clinical Center at the Seattle VA Medical Center, and the Louisville and Seattle Veterans Administration Medical Centers
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1984-09-01
- Volume
- 7
- Issue
- 5
- Pages
- 447-453
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2088352152
- Cited by
- 266
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 10 · 2022: 7 · 2021: 3 · 2020: 6 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 13 · 2013: 15 · 2012: 9
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Keywords
- diabetic autonomic neuropathy, autonomic dysfunction, type 1 diabetes, type 2 diabetes, recent-onset diabetes, heart rate variability, beta-adrenergic blockade, pupil size, furosemide, hypovolemia, carbohydrate metabolism
- MeSH terms
- Adult, Aged, Autonomic Nervous System, Autonomic Nervous System Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Electrocardiography, Female, Heart, Humans, Male, Middle Aged, Reflex, Abnormal, Reflex, Pupillary, Vasomotor System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
